Literature DB >> 28228273

Compliments of Factor H: What's in it for AMD?

Mary J Mattapallil1, Rachel R Caspi2.   

Abstract

Genetic variations in complement factor H (CFH) confer greater risk for age-related macular degeneration (AMD). In this issue of Immunity, Calippe et al. (2017) uncover a non-canonical role for CFH in the inhibition of mononuclear phagocyte elimination from sub-retinal lesions, providing insight into the pathophysiology of AMD associated with CFH variants. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28228273      PMCID： PMC6123247          DOI： 10.1016/j.immuni.2017.02.008

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  9 in total

1.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

Review 2.  A decade of age-related macular degeneration risk models: What have we learned from them and where are we going?

Authors:  Michael Zhang; Paul N Baird
Journal:  Ophthalmic Genet       Date:  2016-11-30       Impact factor: 1.803

3.  Thrombospondin-1 expression in RPE and choroidal neovascular membranes.

Authors:  Shikun He; Francesca Incardona; Manlin Jin; Stephen J Ryan; David R Hinton
Journal:  Yan Ke Xue Bao       Date:  2006-12

4.  Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts.

Authors:  A Pfeiffer; A Böttcher; E Orsó; M Kapinsky; P Nagy; A Bodnár; I Spreitzer; G Liebisch; W Drobnik; K Gempel; M Horn; S Holmer; T Hartung; G Multhoff; G Schütz; H Schindler; A J Ulmer; H Heine; F Stelter; C Schütt; G Rothe; J Szöllôsi; S Damjanovich; G Schmitz
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

Review 5.  Apoptotic cell clearance: basic biology and therapeutic potential.

Authors:  Ivan K H Poon; Christopher D Lucas; Adriano G Rossi; Kodi S Ravichandran
Journal:  Nat Rev Immunol       Date:  2014-01-31       Impact factor: 53.106

6.  Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation.

Authors:  Bertrand Calippe; Sebastien Augustin; Fanny Beguier; Hugo Charles-Messance; Lucie Poupel; Jean-Baptiste Conart; Shulong J Hu; Sophie Lavalette; Alexandre Fauvet; Julie Rayes; Olivier Levy; William Raoul; Catherine Fitting; Thomas Denèfle; Matthew C Pickering; Claire Harris; Sylvie Jorieux; Patrick M Sullivan; José-Alain Sahel; Philippe Karoyan; Przemyslaw Sapieha; Xavier Guillonneau; Emmanuel L Gautier; Florian Sennlaub
Journal:  Immunity       Date:  2017-02-21       Impact factor: 31.745

7.  Prevalence of age-related macular degeneration in the United States.

Authors:  David S Friedman; Benita J O'Colmain; Beatriz Muñoz; Sandra C Tomany; Cathy McCarty; Paulus T V M de Jong; Barbara Nemesure; Paul Mitchell; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

Review 8.  Immunology of age-related macular degeneration.

Authors:  Jayakrishna Ambati; John P Atkinson; Bradley D Gelfand
Journal:  Nat Rev Immunol       Date:  2013-06       Impact factor: 53.106

9.  CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease.

Authors:  Per-Arne Oldenborg
Journal:  ISRN Hematol       Date:  2013-01-21
  9 in total
  6 in total

1.  Selective permeability of mouse blood-aqueous barrier as determined by 15N-heavy isotope tracing and mass spectrometry.

Authors:  Pan Liu; Benjamin R Thomson; Natalia Khalatyan; Liang Feng; Xiaorong Liu; Jeffrey N Savas; Susan E Quaggin; Jing Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

Review 2.  Quality Control Measures and Validation in Gene Association Studies: Lessons for Acute Illness.

Authors:  Maria Cohen; Ashley J Lamparello; Lukas Schimunek; Fayten El-Dehaibi; Rami A Namas; Yan Xu; A Murat Kaynar; Timothy R Billiar; Yoram Vodovotz
Journal:  Shock       Date:  2020-03       Impact factor: 3.533

3.  A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy.

Authors:  Arshad M Khanani; Raj K Maturi; Nika Bagheri; Benjamin Bakall; David S Boyer; Stephen S Couvillion; Dilsher S Dhoot; Nancy M Holekamp; Karim N Jamal; Dennis M Marcus; Dante Pieramici; Aamir A Aziz; Kiran C Patki; William Z Bridges; Samuel B Barone
Journal:  Ophthalmol Sci       Date:  2022-04-11

Review 4.  The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective.

Authors:  Parviz Mammadzada; Pablo M Corredoira; Helder André
Journal:  Cell Mol Life Sci       Date:  2019-12-31       Impact factor: 9.261

Review 5.  Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches.

Authors:  Federico Ricci; Francesco Bandello; Pierluigi Navarra; Giovanni Staurenghi; Michael Stumpp; Marco Zarbin
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

Review 6.  Interactions between Apolipoprotein E Metabolism and Retinal Inflammation in Age-Related Macular Degeneration.

Authors:  Monica L Hu; Joel Quinn; Kanmin Xue
Journal:  Life (Basel)       Date:  2021-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.